Ensemble Therapeutics

About:

Ensemble Therapeutics is focused on the discovery and development of breakthrough small molecule therapies for patients with cancer.

Website: http://ensembletx.com

Twitter/X: ensembletx

Top Investors: ARCH Venture Partners, Oxford Bioscience Partners, Flagship Pioneering

Description:

Total Funding Amount:

$15M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2003-01-01

Contact Email:

info(AT)ensembletx.com

Founders:

David Liu, Noubar Afeyan

Number of Employees:

11-50

Last Funding Date:

2007-01-01

IPO Status:

Private

Industries: